Indegene to acquire marketing services business assets of Canada-based Aptilon
To help clients accelerate their physician engagement strategies
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Archive
Cipla announces major price reduction on select cancer drugs
Cipla Palliative Care Centre completes 15 years of caring for advanced stage cancer patients
Sun Pharma to acquire DUSA Pharmaceuticals
DUSA’s Levulan combination therapy is for treatment of non-hyperkeratotic actinic keratoses
Quintiles study confirms validity of data from patients recruited over Internet
Lays foundation for direct-to-patient studies using patient reported outcomes + medical record methods
Novartis phase III study shows RLX030 improved symptoms and reduced deaths by one-third in patients…
RLX030 is the first in a new class of medicines and the only agent to show a reduction in mortality in AHF
IKP Knowledge Park announces Grand Challenges exploration
The goal of the IKP-GCE programme is to empower ideas that will create new drugs, diagnostics, devices, vaccines, delivery systems…
Pharmexcil expects Ministry notification on branding for drug exports within a week
Notification to clarify status and expected to bring relief to pharma exporters
Glenmark Generics announces settlement of Paragraph IV litigation with Janssen Pharmaceuticals
Glenmark will launch a generic version of ORTHO TRI-CYCLEN LO tablets as early as December 31, 2015
Cipla announces Q2 FY 12-13 unaudited financial results
Gross revenues grew by 23.6 per cent to Rs 2,220 crore
Indoco Remedies posts 13.5 per cent revenue growth in Q2 of FY 2012-13
Net revenues were at Rs.1645.3 million
CDSCO drafts guidelines on recall and rapid alert system for drugs including biologics and vaccines
Targets to enforce in the next three to four months
Biocon delivers healthy growth in H1FY13
Research services and branded formulations propel strong growth
Giving wings to Ideas
The recent past has seen many landmark legal decisions which hinge on intellectual property rights: how they define and protect…
‘India’s patent law has miles to go’
Ranjit Shahani, President, OPPI and Vice Chairman & Managing Director, Novartis India
’Need innovation policy wider than a Patent Act’
Leena Menghaney, India Campaign Manager Access Campaign Médecins Sans Frontières